期刊文献+

免疫球蛋白治疗儿童脓毒症的临床效果及对免疫功能的影响 被引量:2

Clinical effect of immunoglobulin in the treatment of sepsis in children and influence on immune function
下载PDF
导出
摘要 目的探讨免疫球蛋白治疗儿童脓毒症的临床效果及对免疫功能的影响。方法选取2019年5月—2020年4月肇庆市第一人民医院儿科收治的40例脓毒症患儿为研究对象,按照随机抽签法分为对照组(20例)和干预组(20例),对照组进行常规对症治疗,干预组在对照组基础上增加免疫球蛋白治疗,比较两组的治疗效果及治疗前后免疫球蛋白(IgG、IgA、IgM),补体(C3、C4)的水平变化。结果干预组治疗总有效率为90.00%,高于对照组的60.00%,差异有统计学意义(P<0.05)。两组治疗前的IgG、IgA、IgM的水平比较,差异无统计学意义(P>0.05);治疗后干预组的IgG水平高于治疗前,且高于对照组,差异有统计学意义(P<0.05),而两组治疗后的IgA、IgM水平比较,差异无统计学意义(P>0.05)。两组治疗前C3、C4水平比较,差异无统计学意义(P>0.05);两组治疗后的C3、C4水平低于治疗前,且干预组的C3、C4水平低于对照组,差异有统计学意义(P<0.05)。结论免疫球蛋白治疗儿童脓毒症的临床效果显著,能有效改善免疫功能与患儿的临床症状,促进患儿康复,值得推广应用。 Objective To investigate the clinical effect of immunoglobulin in the treatment of children with sepsis and its effect on immune function. Methods A total of 40 children with sepsis treated in the Department of Pediatrics of Zhaoqing First People′s Hospital from May 2019 to April 2020 were selected as the research objects, and divided into control group(20 cases) and intervention group(20 cases) according to random drawing method. The control group received conventional symptomatic treatment, and the intervention group received additional immunoglobulin treatment on the basis of the control group. The therapeutic effect and the levels of immunoglobulin(IgG, IgA, IgM) and complement(C3, C4) before and after treatment were compared between the two groups. Results The total effective rate of the intervention group was 90.00%, which was higher than that of the control group, the difference was statistically significant(P<0.05). There was no significant difference in the levels of IgG, IgA and IgM between the two groups before treatment(P>0.05). After treatment, IgG levels in the intervention group were higher than before treatment and higher than those in the control group, the differences were statistically significant(P<0.05). There was no significant difference in IgA and IgM levels between the two groups after treatment(P>0.05). Before treatment, there was no significant difference in C3 and C4 levels between the two groups(P>0.05). After treatment, the levels of C3 and C4 in the two groups were lower than before treatment, and the levels of C3 and C4 in the intervention group were lower than those in the control group, the differences were statistically significant(P<0.05). Conclusion Immunoglobulin in the treatment of sepsis in children has significant clinical effect, can effectively improve the immune function and clinical symptoms of children,promote the recovery, it is worthy of popularization and application.
作者 伍思贤 贺道机 叶永芝 何海燕 WU Si-xian;HE Dao-ji;YE Yong-zhi;HE Hai-yan(Department of Pediatrics,Zhaoqing First People′s Hospital,Guangdong Province,Zhaoqing526000,China)
出处 《中国当代医药》 CAS 2021年第21期112-114,共3页 China Modern Medicine
基金 广东省肇庆市科技计划项目(201904031010)。
关键词 免疫球蛋白 儿童脓毒症 免疫功能 IGG IGA IGM Immunoglobulin Sepsis in children Immune function IgG IgA IgM
  • 相关文献

参考文献14

二级参考文献99

  • 1曹隽,曹同瓦.静脉用免疫球蛋白对脓毒症的治疗作用[J].中国感染与化疗杂志,2009,9(1):75-77. 被引量:2
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 3Alejandria MM, Lansang MA, Dans LF, et al. Intravenous immunoglobulin for treating sepsis and septic shock [J]. Cochrane Database Syst Rev, 2002, 1 (1): CD001090. DOI: 10.1002/14651858. CD001090.
  • 4Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013, 39 (2): 165- 228. DOI: 10.1007/s00134-012-2769-8.
  • 5Jesdinsky HJ, Tempel G, Castrup HJ, et al. Cooperative Group of Additional Immunoglobulin Therapy in Severe Bacterial Infections: results of a multicenter randomized controlled trial in cases of diffuse fibrinnpurulent peritonitis [J]. Klin Wochenschr, 1987, 65 (23): 1132-1138.
  • 6Dominioni L, Dionigi R, Zanello M, et al. Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater [J]. Arch Surg, 1991, 126 (2): 236-240. DOI: 10.1001/ archsurg. 1991.01410260126018.
  • 7Rodrignez A, Rello J, Neira J, et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery [J]. Shock, 2005, 23 (4): 298-304. DOI: 10.1097/Ol.shk.0000157302.69125.f8.
  • 8Dominioni L, Bianchi V, Imperatori A, et al. High-dose intravenous IgG for treatment of severe surgical infections [J].Dig Surg, 1996, 13 (4-5): 430-434. DOI: 10.1159/000172479.
  • 9Hentrich M, Fehnle K, Ostermann H, et al. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial [J]. Crit Care Med, 2006, 34 (5): 1319-1325. DOI: 10.1097/01.CCM. 0000215452.84291.C6.
  • 10Darenberg J, Ihendyane N, SjOlin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial [J]. Clin Infect Dis, 2003, 37 (3): 333-340. DOI: 10.1086/376630.

共引文献89

同被引文献28

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部